10 research outputs found
Dependence of resting-state-based cerebrovascular reactivity (CVR) mapping on spatial resolution
Cerebrovascular reactivity (CVR) is typically assessed with a carbon dioxide (CO2) stimulus combined with BOLD fMRI. Recently, resting-state (RS) BOLD fMRI has been shown capable of generating CVR maps, providing a potential for broader CVR applications in neuroimaging studies. However, prior RS-CVR studies have primarily been performed at a spatial resolution of 3–4 mm voxel sizes. It remains unknown whether RS-CVR can also be obtained at high-resolution without major degradation in image quality. In this study, we investigated RS-CVR mapping based on resting-state BOLD MRI across a range of spatial resolutions in a group of healthy subjects, in an effort to examine the feasibility of RS-CVR measurement at high resolution. Comparing the results of RS-CVR with the maps obtained by the conventional CO2-inhalation method, our results suggested that good CVR map quality can be obtained at a voxel size as small as 2 mm isotropic. Our results also showed that, RS-CVR maps revealed resolution-dependent sensitivity. However, even at a high resolution of 2 mm isotropic voxel size, the voxel-wise sensitivity is still greater than that of typical task-evoked fMRI. Scan duration affected the sensitivity of RS-CVR mapping, but had no significant effect on its accuracy. These findings suggest that RS-CVR mapping can be applied at a similar resolution as state-of-the-art fMRI studies, which will broaden the use of CVR mapping in basic science and clinical applications including retrospective analysis of previously collected fMRI data
Multi-vendor standardized sequence for edited magnetic resonance spectroscopy
Spectral editing allows direct measurement of low-concentration metabolites, such as GABA, glutathione (GSH) and lactate (Lac), relevant for understanding brain (patho)physiology. The most widely used spectral editing technique is MEGA-PRESS, which has been diversely implemented across research sites and vendors, resulting in variations in the final resolved edited signal. In this paper, we describe an effort to develop a new universal MEGA-PRESS sequence with HERMES functionality for the major MR vendor platforms with standardized RF pulse shapes, durations, amplitudes and timings. New RF pulses were generated for the universal sequence. Phantom experiments were conducted on Philips, Siemens, GE and Canon 3 T MRI scanners using 32-channel head coils. In vivo experiments were performed on the same six subjects on Philips and Siemens scanners, and on two additional subjects, one on GE and one on Canon scanners. On each platform, edited MRS experiments were conducted with the vendor-native and universal MEGA-PRESS sequences for GABA (TE = 68 ms) and Lac editing (TE = 140 ms). Additionally, HERMES for GABA and GSH was performed using the universal sequence at TE = 80 ms. The universal sequence improves inter-vendor similarity of GABA-edited and Lac-edited MEGA-PRESS spectra. The universal HERMES sequence yields both GABA- and GSH-edited spectra with negligible levels of crosstalk on all four platforms, and with strong agreement among vendors for both edited spectra. In vivo GABA+/Cr, Lac/Cr and GSH/Cr ratios showed relatively low variation between scanners using the universal sequence. In conclusion, phantom and in vivo experiments demonstrate successful implementation of the universal sequence across all four major vendors, allowing editing of several metabolites across a range of TEs.publishedVersio
Multi-Vendor and Multisite Evaluation of Cerebrovascular Reactivity Mapping Using Hypercapnia Challenge
Cerebrovascular reactivity (CVR), which measures the ability of cerebral blood vessels to dilate or constrict in response to vasoactive stimuli such as CO2 inhalation, is an important index of the brain\u27s vascular health. Quantification of CVR using BOLD MRI with hypercapnia challenge has shown great promises in research and clinical studies. However, in order for it to be used as a potential imaging biomarker in large-scale and multi-site studies, the reliability of CO2-CVR quantification across different MRI acquisition platforms and researchers/raters must be examined. The goal of this report from the MarkVCID small vessel disease biomarkers consortium is to evaluate the reliability of CO2-CVR quantification in three studies. First, the inter-rater reliability of CO2-CVR data processing was evaluated by having raters from 5 MarkVCID sites process the same 30 CVR datasets using a cloud-based CVR data processing pipeline. Second, the inter-scanner reproducibility of CO2-CVR quantification was assessed in 10 young subjects across two scanners of different vendors. Third, test-retest repeatability was evaluated in 20 elderly subjects from 4 sites with a scan interval of less than 2 weeks. In all studies, the CO2 CVR measurements were performed using the fixed inspiration method, where the subjects wore a nose clip and a mouthpiece and breathed room air and 5% CO2 air contained in a Douglas bag alternatively through their mouth. The results showed that the inter-rater CoV of CVR processing was 0.08 ± 0.08% for whole-brain CVR values and ranged from 0.16% to 0.88% in major brain regions, with ICC of absolute agreement above 0.9959 for all brain regions. Inter-scanner CoV was found to be 6.90 ± 5.08% for whole-brain CVR values, and ranged from 4.69% to 12.71% in major brain regions, which are comparable to intra-session CoVs obtained from the same scanners on the same day. ICC of consistency between the two scanners was 0.8498 for whole-brain CVR and ranged from 0.8052 to 0.9185 across major brain regions. In the test-retest evaluation, test-retest CoV across different days was found to be 18.29 ± 17.12% for whole-brain CVR values, and ranged from 16.58% to 19.52% in major brain regions, with ICC of absolute agreement ranged from 0.6480 to 0.7785. These results demonstrated good inter-rater, inter-scanner, and test-retest reliability in healthy volunteers, and suggested that CO2-CVR has suitable instrumental properties for use as an imaging biomarker of cerebrovascular function in multi-site and longitudinal observational studies and clinical trials
MAGNETIC RESONANCE IMAGING OF CEREBRAL VENOUS OXYGENATION
Cerebral venous oxygenation (Yv) is an important index of the brain’s oxygen metabolism, and has found clinical utility in various diseases, such as multiple sclerosis and Alzheimer’s disease. Traditionally, positron emission tomography (PET) with 15O-labeled radiotracers was considered the gold standard to measure cerebral oxygenation. However, its clinical applications have recently diminished due to inherent limitations such as the invasive procedures and radiation exposure. To facilitate wider clinical applications of Yv as a useful biomarker, this dissertation focuses on the development and validation of non-invasive magnetic resonance imaging (MRI) techniques for Yv measurement.
First, to facilitate technique dissemination and multi-center studies, we harmonized the implementations of T2-relaxation-under-spin-tagging (TRUST), a commonly-used non-invasive MRI technique to measure global Yv, across two major MR vendors, Philips and Siemens. We demonstrated that TRUST provided highly compatible Yv measurements across the two scanners, and had excellent reproducibility and sensitivity to Yv changes on both scanners.
Second, we validated the accuracy of TRUST global Yv estimations with gold standard 15O-PET measurements. We showed that TRUST global Yv measurements strongly correlated with those of 15O-PET and had no systematic bias, suggesting that TRUST can measure global Yv accurately.
Third, to enhance the sensitivity of Yv to diseases, we investigated the physiological underpinnings of normal inter-subject Yv variations. We found that end-tidal CO2 (EtCO2) positively correlated with Yv and explained approximately 50% of inter-subject Yv variations. These findings were reproducible in two different populations (young and elderly) and on two different MR systems (Philips and Siemens). Moreover, accounting for EtCO2, age and systolic blood pressure could reduce the Yv variations by 73%, which may substantially enhance the sensitivity of Yv to diseases.
Last, since certain diseases mainly affect specific brain regions, we developed a novel technique, accelerated-T2-relaxation-under-phase-contrast (aTRUPC), to quantify Yv in major cerebral veins in a particularly challenging population, the neonates. We optimized the sequence parameters and improved the accuracy of Yv quantifications through in-vivo experiments. Then, vessel-specific Yv maps were obtained in healthy non-sedated neonates within 4min, and we found that veins draining the cortical brain had lower Yv than veins draining the central brain
MRI assessment of cerebral oxygen extraction fraction in the medial temporal lobe
The medial temporal lobe (MTL) is a key area implicated in many brain diseases, such as Alzheimer's disease. As a functional biomarker, the oxygen extraction fraction (OEF) of MTL may be more sensitive than structural atrophy of MTL, especially at the early stages of diseases. However, there is a lack of non-invasive techniques to measure MTL-OEF in humans. The goal of this work is to develop an MRI technique to assess MTL-OEF in a clinically practical time without using contrast agents. The proposed method measures venous oxygenation (Yv) in the basal veins of Rosenthal (BVs), which are the major draining veins of the MTL. MTL-OEF can then be estimated as the arterio-venous difference in oxygenation. We developed an MRI sequence, dubbed arterial-suppressed accelerated T2-relaxation-under-phase-contrast (AS-aTRUPC), to quantify the blood T2 of the BVs, which was then converted to Yv through a well-established calibration model. MTL-OEF was calculated as (Ya−Yv)/Ya × 100%, where Ya was the arterial oxygenation. The feasibility of AS-aTRUPC to quantify MTL-OEF was evaluated in 16 healthy adults. The sensitivity of AS-aTRUPC in detecting OEF changes was assessed by a caffeine ingestion (200 mg) challenge. For comparison, T2-relaxation-under-spin-tagging (TRUST) MRI, which is a widely used global OEF technique, was also acquired. The dependence of MTL-OEF on age was examined by including another seven healthy elderly subjects. The results showed that in healthy adults, MTL-OEF of the left and right hemispheres were correlated (P=0.005). MTL-OEF was measured to be 23.9±3.6% (mean±standard deviation) and was significantly lower (P<0.0001) than the OEF of 33.3±2.9% measured in superior sagittal sinus (SSS). After caffeine ingestion, there was an absolute percentage increase of 9.1±4.0% in MTL-OEF. Additionally, OEF in SSS measured with AS-aTRUPC showed a strong correlation with TRUST OEF (intra-class correlation coefficient=0.94 with 95% confidence interval [0.91, 0.96]), with no significant bias (P=0.12). MTL-OEF was found to increase with age (MTL-OEF=20.997+0.100 × age; P=0.02). In conclusion, AS-aTRUPC MRI provides non-invasive assessments of MTL-OEF and may facilitate future clinical applications of MTL-OEF as a disease biomarker
Multi-vendor standardized sequence for edited magnetic resonance spectroscopy
Spectral editing allows direct measurement of low-concentration metabolites, such as GABA, glutathione (GSH) and lactate (Lac), relevant for understanding brain (patho)physiology. The most widely used spectral editing technique is MEGA-PRESS, which has been diversely implemented across research sites and vendors, resulting in variations in the final resolved edited signal. In this paper, we describe an effort to develop a new universal MEGA-PRESS sequence with HERMES functionality for the major MR vendor platforms with standardized RF pulse shapes, durations, amplitudes and timings. New RF pulses were generated for the universal sequence. Phantom experiments were conducted on Philips, Siemens, GE and Canon 3 T MRI scanners using 32-channel head coils. In vivo experiments were performed on the same six subjects on Philips and Siemens scanners, and on two additional subjects, one on GE and one on Canon scanners. On each platform, edited MRS experiments were conducted with the vendor-native and universal MEGA-PRESS sequences for GABA (TE = 68 ms) and Lac editing (TE = 140 ms). Additionally, HERMES for GABA and GSH was performed using the universal sequence at TE = 80 ms. The universal sequence improves inter-vendor similarity of GABA-edited and Lac-edited MEGA-PRESS spectra. The universal HERMES sequence yields both GABA- and GSH-edited spectra with negligible levels of crosstalk on all four platforms, and with strong agreement among vendors for both edited spectra. In vivo GABA+/Cr, Lac/Cr and GSH/Cr ratios showed relatively low variation between scanners using the universal sequence. In conclusion, phantom and in vivo experiments demonstrate successful implementation of the universal sequence across all four major vendors, allowing editing of several metabolites across a range of TEs
Deep-learning-enabled Brain Hemodynamic Mapping Using Resting-state fMRI
Cerebrovascular disease is a leading cause of death globally. Prevention and
early intervention are known to be the most effective forms of its management.
Non-invasive imaging methods hold great promises for early stratification, but
at present lack the sensitivity for personalized prognosis. Resting-state
functional magnetic resonance imaging (rs-fMRI), a powerful tool previously
used for mapping neural activity, is available in most hospitals. Here we show
that rs-fMRI can be used to map cerebral hemodynamic function and delineate
impairment. By exploiting time variations in breathing pattern during rs-fMRI,
deep learning enables reproducible mapping of cerebrovascular reactivity (CVR)
and bolus arrive time (BAT) of the human brain using resting-state CO2
fluctuations as a natural 'contrast media'. The deep-learning network was
trained with CVR and BAT maps obtained with a reference method of
CO2-inhalation MRI, which included data from young and older healthy subjects
and patients with Moyamoya disease and brain tumors. We demonstrate the
performance of deep-learning cerebrovascular mapping in the detection of
vascular abnormalities, evaluation of revascularization effects, and vascular
alterations in normal aging. In addition, cerebrovascular maps obtained with
the proposed method exhibited excellent reproducibility in both healthy
volunteers and stroke patients. Deep-learning resting-state vascular imaging
has the potential to become a useful tool in clinical cerebrovascular imaging